Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

0.1667 -0.0182 (-9.84%)
Streaming Delayed Price Updated: 10:33 AM EST, Dec 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Applied Dna Scns

< Previous 1 2 3 4 5 Next >
Applied DNA Completes Technical Validation of PCR-based SARS-CoV-2 Mutation-Detection Panel, Highlights Ability to Rapidly Identify Mutations and Probable Variants
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Provides Clarification on Newly Authorized Asymptomatic Serial Screening Indication for LineaTM COVID-19 Assay Kit and Press Release Published 12 May 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Second Fiscal Quarter 2021 Financial Results Feature 384% Year-Over-Year Growth in Revenues
From Applied DNA Sciences, Inc.
Via Business Wire
FDA Grants EUA to Applied DNA LineaTM COVID-19 Assay Kit for Asymptomatic Screening of Individuals with Serial Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Receives CLIA Certification, Enabling High Throughput Diagnostic COVID-19 Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fiscal 2021 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 13, 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Signs New Contract with U.S. Defense Logistics Agency
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Secures Amendment to Master Services Agreement and Fourth Blanket Purchase Order from Linea™ COVID-19 Assay Kit Customer
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Provides Preliminary Estimated Fiscal Second Quarter 2021 Revenue Range and Business Update
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial for LinearDNA™ COVID-19 Vaccine Candidate in Felines
From Applied DNA Sciences, Inc. and Takis Biotech/Evvivax
Via Business Wire
Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Northwell Health Establish SARS-CoV-2 Mutation and Variant Tracking Program
From Applied DNA Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.